Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 7,051 | 7,587 | 5,938 | 8,869 | 4,354 |
| Operating Income | -7,051 | -7,587 | -5,938 | -8,869 | -4,354 |
| Other Income | 247 | 312 | 411 | 13,036 | -5,225 |
| Pre-tax Income | -6,804 | -7,275 | -5,527 | 4,167 | -9,579 |
| Net Income Continuous | -6,804 | -7,275 | -5,527 | 4,167 | -9,579 |
| Net Income | $-6,804 | $-7,275 | $-5,527 | $4,167 | $-9,579 |
| EPS Basic Total Ops | -0.73 | 1.34 | -0.59 | 0.51 | -3.72 |
| EPS Basic Continuous Ops | -0.73 | 1.35 | -0.59 | 0.51 | -3.72 |
| EPS Diluted Total Ops | -0.73 | 2.05 | -0.59 | -1.00 | -3.72 |
| EPS Diluted Continuous Ops | -0.73 | 1.48 | -0.59 | 0.49 | -3.72 |
| EPS Diluted Before Non-Recurring Items | -0.73 | -0.78 | -0.59 | -1.00 | -3.22 |
| EBITDA(a) | $-7,027 | $-7,763 | $-5,914 | $-8,846 | $-4,330 |